Asociación entre el puntaje del cuestionario de Clarke y las métricas aportadas por el monitoreo continuo de glucosa en pacientes con diabetes y alto riesgo de hipoglucemia
Authors:
- Diana Cristina Henao-CarrilloDHDiana Cristina Henao-Carrillo
- Ana Maria Gómez MedinaAMAna Maria Gómez Medina
- Alejandro García-CajiaoAGAlejandro García-Cajiao
- Sofia Robledo GómezSGSofia Robledo Gómez
- Gabriela Mejía PiñaGPGabriela Mejía Piña
- Salma Nicole Chahin PadillaSPSalma Nicole Chahin Padilla
- Alfonso KerguelenAKAlfonso Kerguelen
- Claudia Patricia RubioCRClaudia Patricia Rubio
- Martin RondónMRMartin Rondón
- Oscar Mauricio MuñozOMOscar Mauricio Muñoz
Open Access
- 14 July 2023
- journal article
- Published by Asociacion Colombiana de Endocrinologia, Diabetes y Metabolismo in Revista Colombiana de Endocrinología, Diabetes & Metabolismo
- Vol. 10 (3)
Abstract
Background: The Clarke Questionnaire (CQ) determines the perception of hypoglycemia symptoms, and a score ?4 detects patients with Hypoglycemia unawareness (HU). Evidence regarding the association between Continuous Glucose Monitoring (CGM) metrics and the CQ score is limited. Purpose: To describe the association between the CQ score and CGM metrics in patients diagnosed with diabetes treated with insulin at high risk of hypoglycemia. Methodology: A cross-sectional study in adult patients with diabetes diagnostic, treated with insulin and a history of severe hypoglycemia or risk factors for hypoglycemia unawareness (HU). Firstly, Baseline demographic, clinical, and Clarke score data were recorded; secondly, a professional CGM was performed for six days. Finally, CGM metrics were compared for the groups with or without hypoglycemia unawareness, using different cut-off points (Clarke ? 4 and Clarke ? 3). Results: 83 patients were included (median age 63 years old [IQR 53.5-70.5], DM2 63.9%, HbA1c 7.6±1.6%). The median of time in range (%TIR 70-180mg/dl) was 75% [RIC 63-92], time above range (%TAR>180mg/dl) was 15% [3-27], and the median time below range (%TBR< 70mg/dl) 3% (IQR 1-7). In patients with Clarke ?4 the %TIR was lower (Median 55[RIC 41-89] vs 77[RIC 68-92], p=0.05) at the expense of higher %TAR (Median 23[IQR 7-54] vs 15[IQR 3-16], p=0.15). No significant differences were found in %TBR<70mg/dl. Conclusions: HU was associated with a lower %TIR between 70-180 mg/dL in a clinically and statistically significant way in patients using insulin with risk factors for hypoglycemia. Contexto: el cuestionario de Clarke (CC), determina la percepción de síntomas de hipoglucemia y un puntaje ?4 detecta pacientes con hipoglucemia inadvertida (HI). La evidencia sobre la asociación entre las métricas del Monitoreo Continuo de Glucosa (MCG) y el puntaje del CC es limitada. Objetivo: describir la asociación entre el puntaje del CC y métricas del MCG en pacientes con diagnóstico de diabetes tratados con insulina y alto riesgo de hipoglucemia. Metodología: estudio de corte transversal, en pacientes adultos con diagnóstico de diabetes tratados con insulina e historia de hipoglucemia severa o factores de riesgo para (HI). Se registraron datos demográficos, clínicos y puntaje de Clarke basales. Se realizó MCG profesional durante 6 días. Se compararon las métricas del MCG para los grupos con o sin HI, utilizando diferentes puntos de corte (Clarke ?4 y ?3). Resultados: se incluyeron 83 pacientes (mediana de edad 63 años [RIC 53.5-70.5], 71.1% DM2, HbA1c 7.6±1.6%). La mediana de tiempo en rango (TIR70-180 mg/dL) fue 75% [RIC 63-92], tiempo debajo rango (TBR180 mg/dL 15% [3-27]. En pacientes con Clarke ?4 el %TIR fue menor (Mediana 55[RIC 41-89] vs 77[RIC 68-92], p=0.05) a expensas de mayor %TAR (Mediana 23[RIC 7-54] vs 15[RIC 3-16], p=0.15). No se encontraron diferencias significativas en %TBR<70mg/dl. Conclusiones: HI se asoció a menor %TIR entre 70-180 mg/dL de forma clínica y estadísticamente significativa en pacientes usuarios de insulina con factores de riesgo para hipoglucemia.Keywords
This publication has 27 references indexed in Scilit:
- Hypoglycemia unawareness in type 1 diabetes patients using intermittent continuous glucose monitoring: Identification of risk factors and glycemic patternsDiabetes & Metabolic Syndrome: Clinical Research & Reviews, 2022
- The consequences of hypoglycaemiaDiabetologia, 2021
- Factors associated with clinically significant hypoglycemia in patients with type 1 diabetes using sensor-augmented pump therapy with predictive low-glucose management: A multicentric study on iberoamericaDiabetes & Metabolic Syndrome: Clinical Research & Reviews, 2021
- Insulin glargine 300 U/mL and insulin degludec: A review of the current evidence comparing these two second‐generation basal insulin analoguesDiabetes/Metabolism Research and Reviews, 2020
- Hypoglycemia Among Patients with Type 2 Diabetes: Epidemiology, Risk Factors, and Prevention StrategiesCurrent Diabetes Reports, 2018
- Reduction of glycemic variability with Degludec insulin in patients with unstable diabetesJournal of Clinical & Translational Endocrinology, 2018
- Impact of Hypoglycemia on Brain Metabolism During DiabetesMolecular Neurobiology, 2018
- Impact of hypoglycaemia on patient-reported outcomes from a global, 24-country study of 27,585 people with type 1 and insulin-treated type 2 diabetesDiabetes Research and Clinical Practice, 2017
- Psychometric analysis of the Spanish and Catalan versions of a questionnaire for hypoglycemia awarenessMedicina Clínica (English Edition), 2015
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987